Wednesday, July 8, 2026

pharma · ADHD · Idiopathic Hypersomnia · ZVRA

ZEVRA THERAPEUTICS

ZEVRA THERAPEUTICS clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Boston, USA HQ
2006 Founded
81 Employees
Public company Type
ZVRA · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2006
Employees
81
Programs
4
Drugs
6
Patents
5
Intelligence · Clinical Programs

ZEVRA THERAPEUTICS projects

1 ClinicalTrials.gov programs sponsored by ZEVRA THERAPEUTICS.

ZEVRA THERAPEUTICS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. KP415 oral capsule

    ZEVRA THERAPEUTICS, INC.

    ADHD

    phase 3 small molecule completed

    2 trials

Frequently asked questions

How many clinical projects does ZEVRA THERAPEUTICS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.